Literature DB >> 14579120

New insights into Parkinson's disease.

Kenny K K Chung1, Valina L Dawson, Ted M Dawson.   

Abstract

Parkinson's disease (PD) is the most common neurodegenerative movement disorder. Recent advances in genetics and pathophysiology have led to new insights into the pathogenesis of PD. Ten loci have been linked to hereditary PD. Mutations in alpha-synuclein and ubiquitin carboxy hydrolase L1 (UchL1) cause autosomal dominant PD and mutations in parkin and DJ-1 cause autosomal recessive PD. alpha-Synuclein has emerged as an important protein in the pathogenesis of PD, as it appears to be the major structural component of Lewy bodies and its accumulation/aggregation seems to play a prominent role in sporadic PD. Mutations in parkin are the most common cause of hereditary PD, and mutations in parkin are thought to lead to a loss of parkin's ubiquitin E3 ligase activity. Derangements in parkin function as well as mutations in UCH-L1 fit with the notion that derangements in the ubiquitin proteasomal pathway (UPP) may play important roles in the demise of dopamine neurons in PD. DJ-1 is a protein of unknown function that is linked to autosomal recessive PD. Oxidative stress and impairment in mitochondrial complex I activity are important in sporadic PD, and there is emerging interest in the role of herbicides, fungicides and insecticides that inhibit mitochondrial complex I activity and their role in contributing to the development of PD. These important findings serve as the foundation for discovering new pathways that may lead to the development of new therapies for PD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14579120     DOI: 10.1007/s00415-003-1304-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  23 in total

1.  Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy.

Authors:  Catherine Meyer-Schwesinger; Tobias N Meyer; Henning Sievert; Elion Hoxha; Marlies Sachs; Eva-Maria Klupp; Silvia Münster; Stefan Balabanov; Lucie Carrier; Udo Helmchen; Friedrich Thaiss; Rolf A K Stahl
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Quinone-induced protein handling changes: implications for major protein handling systems in quinone-mediated toxicity.

Authors:  Rui Xiong; David Siegel; David Ross
Journal:  Toxicol Appl Pharmacol       Date:  2014-08-22       Impact factor: 4.219

Review 3.  Pharmacological study of the novel compound FLZ against experimental Parkinson's models and its active mechanism.

Authors:  Weihong Feng; Huailing Wei; Geng Tao Liu
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

4.  Absence of glia maturation factor protects dopaminergic neurons and improves motor behavior in mouse model of parkinsonism.

Authors:  Mohammad Moshahid Khan; Smita Zaheer; Ramasamy Thangavel; Margi Patel; Duraisamy Kempuraj; Asgar Zaheer
Journal:  Neurochem Res       Date:  2015-03-10       Impact factor: 3.996

5.  Neuroprotective Effects of β-Asarone Against 6-Hydroxy Dopamine-Induced Parkinsonism via JNK/Bcl-2/Beclin-1 Pathway.

Authors:  Sheng Zhang; Xue-Hong Gui; Li-Ping Huang; Min-Zhen Deng; Ruo-Ming Fang; Xue-Hong Ke; Yu-Ping He; Ling Li; Yong-Qi Fang
Journal:  Mol Neurobiol       Date:  2014-11-18       Impact factor: 5.590

Review 6.  Mouse models of mitochondrial complex I dysfunction.

Authors:  Michael H Irwin; Kodeeswaran Parameshwaran; Carl A Pinkert
Journal:  Int J Biochem Cell Biol       Date:  2012-08-10       Impact factor: 5.085

7.  Learning at old age: a study on winter bees.

Authors:  Andreas Behrends; Ricarda Scheiner
Journal:  Front Behav Neurosci       Date:  2010-04-13       Impact factor: 3.558

8.  Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity.

Authors:  Ming Tong; Matthew Dong; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 9.  Cysteine cathepsins in neurological disorders.

Authors:  Anja Pišlar; Janko Kos
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

10.  The activation sequence of cellular protein handling systems after proteasomal inhibition in dopaminergic cells.

Authors:  Rui Xiong; David Siegel; David Ross
Journal:  Chem Biol Interact       Date:  2013-05-14       Impact factor: 5.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.